Glutamate Flashcards

1
Q

Describe the synthesis of glutamate?

  • Enzyme required?
A
  • Glutamine—————> Glutamate
    • via the use of the enzyme Glutaminase, H20 and ATP.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

State the 3 different vesicular glutamate transporters?

  • Locations of each?
  • function?
  • Results of KO in these VGLUT?
A

VGLUT1,VGLUT2 and VGLUT3.

  • Locations:
    • VGLUT1: cortex and the hippocampus.
    • VGLUT2: Subcortical regions.
    • VGLUT3: expressed in hippocampus and cortex; but less expressed.

VGLUT1 KO: mice survive, but begin to die after 3rd week.

VGLUT2 KO: mice die immediately after birth.

VGLUT3 KO: mice are viable but are completely deaf, as the cochlea uses glutamate via hair cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How are glutamate and aspartate taken up from the synaptic cleft?

  • Name and state the location of each of these transporters[5 marks].
A

Excitatory amino acid transporters EAAT1 to EAAT5.

  • EAAT1: located in the cerebellum within glial cells.
  • EAAT2: located in astrocytes throughout the brain.
  • EAAT3: throughout the brain, as it is the main neuronal glutamate transporter.
  • EAAT4: purkinje cells in the cerebellum.
  • EAAT5: present within several type of cells in the retina.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is glutamate transported from the synaptic cleft?

  • What occurs if achieved via EAAT3?
  • What occurs if transported back into EAAT1 or EAAT2?
A

EAAT3:

  • Glutamate taken up and reloaded into VGLUT.

EAAT1 or EAAT2:

  • Astrocytes convert glutamate into Glutamine, via Glutamine synthase.
    • when transported out of astrocytes glutaminase is used to convert it back to glutamate.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What cells use glutamate as their main neurotransmitter?

A
  • Pyramidal neurons within the cortex.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

State the ionotropic receptors for glutamate?

A
  • AMPA receptors.
  • Kainate receptors.
  • NMDA receptors.

overall fast signaling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

the difference in ions transported within the 3 different types?

A
  • AMPA and Kainate receptors:
    • flow of Na+ depolarises.
  • NMDA receptors: allows both Na+ and Ca2+ to pass:
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Unique characteristics of NMDA receptors?

A
  • Flow of both Na+ and Ca2+.
  • Require co-agonists with glutamate to open channel:
    • Glycine or D-serine.
  • Mg2+ blocks the channel, at resting potential (-70mv).
    • when depolarised, Mg2+ is dissociated.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

State some non-competitive inhibitors of NMDA receptors.

A
  • Ketamine.
  • Phencyclidine(PCP).
  • MK-801( dizocilpine),
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

State all the metabotropic glutamate receptors?

Mechanism?

A
  • mGluR1-mGluR8.
    • G-protein,
      • can inhibit c-AMP formation.
      • Other activates Phosphoinositide second messenger system,(mGluR1-mGluR5).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The function of L-AP4( L-2-amino-4-phosphonobutyrate)?

Function of metabotropic receptors?

A
  • Selective agonist for glutamate autoreceptors.
    • suppressing glutamatergic synaptic transmission.

Metabotropic receptor function:

  • for locomotor activity , cognition, motor coordination, mood and pain.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clinical applications in Agonists of mGluR2?

A
  • inhibits glutamate release in experimental animals.
  • for patients with schizophrenia and neuropsychiatric disorders.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Function of Nootropics?

Function of Ampakines?

A

Nootropics:

  • improve cognitive function.
  • Acts on the cholinergic system.
  • others target the glutamate receptors.

Ampakines:

  • Enhance the action of AMPA receptors, by reducing rate desensitization, improving cognitive function to treat neuropsychiatric disorders.
    • however no positive results on human trials.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Results of experimentation on treatment of NMDA receptor antagonists?

Results of the Doogie mouse overexpressing the NR2B subunit on the NMDA receptor?

A

NMDA receptor antagonists:

  • impaired spatial learning:
    • as a high number of NMDA neurons in the hippocampus.

Doogie mouse, with ++NR2B on NMDA receptor:

  • enhanced LTP and improved learning in memory test;
    • e.g. novel recognition tasks.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly